The NIH, Corporate Sponsors, and Research

July 16, 2018 by C. Scott McMillin

So if some enterprising MD or PhD were to show with a proposal for research designed to prove that drinking has definite health benefits, the industry will throw money at it.

Topics: ,


The Vaping Dilemma

July 5, 2018 by C. Scott McMillin

From a seller’s viewpoint, no customer is more desirable than someone who is actually dependent on their product.

Topics: , ,


Striking a Cannabis Balance

July 2, 2018 by C. Scott McMillin

…just as repeal of Prohibition didn’t make alcohol any safer for popular use… neither will legalization remove the risks associated with cannabis.

Topics: ,


Is Relapse a Crime?

June 28, 2018 by C. Scott McMillin

But if a community treats a correctional institution as a kind of locked flophouse, what else we can expect?

Topics: , , ,


Opioid Settlements?

June 21, 2018 by C. Scott McMillin

“…over the past five years, less than 10% of the nearly $40 billion in tobacco payments went towards such efforts.”

Topics: , ,


Conflict of Interest Case Study

June 18, 2018 by C. Scott McMillin

Obviously, being able to give your own business a five star rating on a supposedly independent consumer website could be construed as an unfair advantage.

Topics: ,


“Invisible” Hand? Or “Absent” Hand?

June 11, 2018 by C. Scott McMillin

In their eagerness to reduce the size of government, states  have stripped away staff who would otherwise make onsite visits to ensure compliance.

Topics: ,


Who’s Looking Out for You?

June 7, 2018 by C. Scott McMillin

Sometimes powerful business leaders sound like drunk drivers or corner drug dealers. Rationalizing, externalizing, minimizing…

Topics: ,


In the News: Opioid Addiction and the Private Sector

June 4, 2018 by C. Scott McMillin

Portman argues that since business and industry will directly benefit, they should take an active or even a leadership role in this effort.

Topics: ,


Needle Exchange Backlash

May 24, 2018 by C. Scott McMillin

Nonetheless, in most instances it’s an a priori resistance rooted in fear, rather than legitimate objections.

Topics: , , ,


Subscribe to RecoverySI via Email

Join 2,377 other subscribers


New Content